NLS Pharmaceutics
NLSP
NLSP
7 hedge funds and large institutions have $145K invested in NLS Pharmaceutics in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
+2
Holders Change %
+40%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Two Sigma Investments
New York
|
$51K |
| 2 |
HF
2
HRT Financial
New York
|
$15K |
| 3 |
VF
3
Virtu Financial
New York
|
$12K |
| 4 |
4
Renaissance Technologies
New York
|
$12K |
Top Sellers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$14K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$0 |
| 3 |
TSS
3
Two Sigma Securities
New York
|
$0 |
| 4 |
4
Two Sigma Advisers
New York
|
$25K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Two Sigma Investments
New York
| $51K | +$51K | +1,147 | New |
|
|
2
Two Sigma Advisers
New York
| $25K | -$4.96K | -113 | -17% |
|
3
Geode Capital Management
Boston,
Massachusetts
| $16K | – | – | – |
|
|
HF
4
HRT Financial
New York
| $15K | +$15K | +351 | New |
|
|
5
UBS Group
Zurich,
Switzerland
| $14K | -$54.6K | -1,243 | -80% |
|
|
VF
6
Virtu Financial
New York
| $12K | +$12K | +265 | New |
|
|
7
Renaissance Technologies
New York
| $12K | +$12K | +270 | New |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$51K | -511 | Closed |
|
|
TSS
9
Two Sigma Securities
New York
| – | -$25K | -254 | Closed |
|